ClinicalTrials.gov
public full text
Public Domain
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia#862737
- Heparin continuous infusion for thromboprophylaxis in pediatric liver transplant recipients.#472524
- Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment#981622
- Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery#866731
- Prospective Analysis of the Use of TEG in Stroke Patients#1031498
Record · ID 966489
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive